C18 Ganglioside GM2-d7 (d18:1/18:0-d7) (ammonium salt, synthetic)

C18 Ganglioside GM2-d7 (d18:1/18:0-d7) (ammonium salt, synthetic)
Artikelnummer
CAY39641-250
Verpackungseinheit
250 µg
Hersteller
Cayman Chemical

Verfügbarkeit: wird geladen...
Preis wird geladen...
Formulation: A solution in methanol

Formal Name: (2S,4S,5R,6R)-5-acetamido-2-(((2R,3S,4R,5R,6S)-3-(((2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-6-(((2R,3S,4R,5R,6R)-4,5-dihydroxy-6-(((2S,3R,E)-3-hydroxy-2-(octadecanamido-16,16,17,17,18,18,18-d7)octadec-4-en-1-yl)oxy)-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-5-hydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)oxy)-4-hydroxy-6-((1R,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-carboxylate, monoammonium salt

Purity: ≥99% deuterated forms (d1-d7)

Formula Markup: C67H113D7N3O26 • NH4

Formula Weight: 1408,8

Shelf life (days): 730

Notes: C18 Ganglioside GM2-d7 (d18:1/18:0-d7) is intended for use as an internal standard for the quantification of C18 ganglioside GM2 by GC- or LC-MS. C18 Ganglioside GM2 is a monosialylated ganglioside found in the mammalian brain where it is localized to the cell membrane.{40894} It accumulates in Tay-Sachs and Sandhoff disease, which are neurodegenerative disorders characterized by deficiency of lysosomal β-hexosaminidase A and B, respectively.{40891} Ganglioside GM2 disrupts the function of immune cells and, when used at a concentration of 25 µM, increases migration and invasion of SK-RC-45 cells with no effect on proliferation.{39686} This product is fully synthetic and has no variations in the fatty acyl chain or sphingoid backbone. It is intended for use as an analytical standard for the quantification of C18 ganglioside GM2 by GC-MS.
Mehr Informationen
Artikelnummer CAY39641-250
Hersteller Cayman Chemical
Hersteller Artikelnummer 39641-250
Verpackungseinheit 250 µg
Mengeneinheit STK
Methode GC-MS, LC-MS, Isotopenmarkierung
Produktinformation (PDF) Download
MSDS (PDF) Download